vadadustat sold brand name vafseo medication used treatment symptomatic anemia associated chronic kidney common side effects include thromboembolic events problems due formation blood clots blood vessels diarrhea hypertension high blood vadadustat approved medical use european union april vadadustat indicated treatment symptomatic anemia associated chronic kidney disease adults chronic maintenance february committee medicinal products human use chmp european medicines agency ema adopted positive opinion recommending granting marketing authorization medicinal product vafseo intended treatment symptomatic anemia adults chronic kidney disease chronic applicant medicinal product akebia europe vadadustat approved medical use european union april vadadustat phase iii clinical trials treatment anemia caused chronic kidney drug article relating blood blood forming organs stub help wikipedia expanding ithttpsenwikipediaorgwikivadadustat